Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-01-16 Sale | 2020-01-21 4:44 pm | HOOKIPA Pharma Inc. | HOOK | Orlinger Klaus Sr. VP, Research | 8,500 | $11.93 | $101,373 | 22,271 (Direct) | View |
| 2020-01-14 Sale | 2020-01-16 4:06 pm | HOOKIPA Pharma Inc. | HOOK | Orlinger Klaus Sr. VP, Research | 8,500 | $11.3 | $96,053 | 1,140 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-15 Option Award | 2024-04-17 4:15 pm | N/A 2034-04-15 | HOOKIPA Pharma Inc. | HOOK | Orlinger Klaus Chief Scientific Officer | 367,300 | $0 | 367,300 (Direct) | View |
| 2023-04-14 Option Award | 2023-04-18 7:50 pm | N/A 2033-04-14 | HOOKIPA Pharma Inc. | HOOK | Orlinger Klaus Chief Scientific Officer | 194,200 | $0 | 194,200 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-01 4:13 pm | N/A 2032-04-19 | HOOKIPA Pharma Inc. | HOOK | Orlinger Klaus Chief Scientific Officer | 48,350 | $0 | 48,350 (Direct) | View |
| 2022-04-19 Option Award | 2022-04-20 4:30 pm | N/A 2032-04-19 | HOOKIPA Pharma Inc. | HOOK | Orlinger Klaus Chief Scientific Officer | 48,350 | $0 | 48,350 (Direct) | View |
| 2022-02-01 Option Award | 2022-02-01 8:52 pm | N/A 2032-01-31 | HOOKIPA Pharma Inc. | HOOK | Orlinger Klaus Executive VP, Research | 21,842 | $3 | 23,058 (Direct) | View |
| 2021-04-19 Option Award | 2021-04-21 4:38 pm | N/A 2031-04-19 | HOOKIPA Pharma Inc. | HOOK | Orlinger Klaus Sr. VP, Research | 26,050 | $0 | 26,050 (Direct) | View |
| 2020-07-20 Option Award | 2020-07-22 4:02 pm | N/A N/A | HOOKIPA Pharma Inc. | HOOK | Orlinger Klaus EVP, Research | 1,216 | $0 | 1,216 (Direct) | View |
| 2020-04-20 Option Award | 2020-04-24 08:55 am | N/A 2030-04-20 | HOOKIPA Pharma Inc. | HOOK | Orlinger Klaus EVP, Research | 30,000 | $0 | 0 (Direct) | View |
| 2020-01-16 Exercise | 2020-01-21 4:44 pm | N/A 2026-12-31 | HOOKIPA Pharma Inc. | HOOK | Orlinger Klaus Sr. VP, Research | 8,500 | $0 | 22,271 (Direct) | View |
| 2020-01-16 Exercise | 2020-01-21 4:44 pm | N/A N/A | HOOKIPA Pharma Inc. | HOOK | Orlinger Klaus Sr. VP, Research | 8,500 | $0.1 | 22,271 (Direct) | View |
| 2020-01-14 Exercise | 2020-01-16 4:06 pm | N/A 2026-12-31 | HOOKIPA Pharma Inc. | HOOK | Orlinger Klaus Sr. VP, Research | 8,500 | $0 | 1,140 (Direct) | View |
| 2020-01-14 Exercise | 2020-01-16 4:06 pm | N/A N/A | HOOKIPA Pharma Inc. | HOOK | Orlinger Klaus Sr. VP, Research | 8,500 | $0.1 | 1,140 (Direct) | View |